Category Archives: Public Policy

Latest From Public Policy

University Licensing Survey 2010 – AUTM

AUTM is set to release their AUTM Licensing Activity Survey Summary: FY 2010 in the fall of this year for both the U.S. and Canada.  AUTM issued a AUTM 2010 survey highlights to wet the appetite. Highlights: -The number of startups formed increased 10.6%.  651 startup companies formed of which 498 had their primary place of business in the licensing institution’s home state. -Number of licenses/options executed to startups increased 14%.  4,284 licenses executed and Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Quandary for U.S. companies: Whom to bribe? (Washington Post)


From this Sunday’s Washington Post, David Hilzenrath lays out ambiguities of the Foreign Corrupt Practices Act. Scientific American’s Worldview 2011 report compares corruption among countries seeking to grow the biotech industry within their borders based on the 2010 Corruption Perceptions Index from Transparency International. Countries that ranked high in perceived corruption tended to rank lower in terms of overall innovation. In other words, as corruption increases, the nation’s business reputation sinks while those with a Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , ,

Bayh Dole Act a Failure? Part II: The Comments

By Guest Joseph Allen Yesterday we posted the reply of Robin Rasor, President of the Assn of University Technology Managers, to a Washington Post opinion piece by Vivek Wadhwa asserting that the university/industry technology transfer model established under the Bayh-Dole Act had failed and should be replaced.  The article set off a series of comments, the most interesting of which occurred when Mr Wadhwa challenged Rasor to document the statistics she used asserting the Bayh-Dole Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Public Opinion: What do voters think about biotechnology?


The majority of voters recognize the important work being conducted at biotech companies and place a high value on the industry’s contributions. After only a brief neutral description of the biotechnology industry, 87% of those polled have a favorable image of the biotech industry. More than three-quarters of Americans surveyed are convinced that biotech is working every day on curing diseases such as Alzheimer’s, cancer, diabetes and Parinson’s. Furthermore, they believe that these cures will Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

Bayh Dole Act a failure?

By Guest Writer Joseph Allen One hotly debated topic in Washington of real importance to the biotechnology community is how well the annual multi-billion dollar federal investment in R&D is being translated into new products, jobs and companies needed to improve the lives of US taxpayers and help pull the US economy out of its current doldrums.  An interesting insight on the debate is captured in a Washington Post article “Innovation’s golden opportunity” that ran Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , ,